Skip to content
Governance Register
Sign inFind yourself
Find yourselfSign in
Search How it works For organisations For professionals

Edition

United Kingdom (current)IrelandUnited StatesNew ZealandCanadaAustraliaScotlandNorthern Ireland

Company

Teva UK Limited

Teva UK Limited is an active UK company (number 00302461), incorporated 1935, with 2 current directors, Stephen Michael Charlesworth and Kim Innes. Source: Companies House, updated 4th October 2026.

How am I connected?
More
View network map Report an issue

Official record Companies House · updated 4th October 2026 · Sources

Network

The large node is Teva UK Limited. Red nodes are organisations, white nodes are people. Sign in free to explore further.

Who leads it

Previous officers 25

  1. Dean Michael Cooper 2018-2020 Director View profile
  2. David Vrhovec 2016-2026 Director View profile
  3. Robert Williams 2016-2018 Director View profile
  4. Richard Gordon Daniell 2016-2016 Director View profile
  5. Stephen Philip Oldfield 2015-2016 Director View profile
  6. Tim Oreskovic 2014-2016 Director View profile
  7. Gertjan Noordermeer 2014-2014 Director View profile
  8. Michael Schrewe 2013-2016 Director View profile
  9. Robert Koremans 2012-2014 Director View profile
  10. Dipankar Bhattacharjee 2009-2011 Director View profile
  11. John Beighton 2002-2009 Director View profile
  12. Meron Mann 2002-2006 Director View profile
  13. Peter Horsman 1997-2009 Director View profile
  14. Theo Jacobus Andriessen 1997-2012 Director View profile
  15. Eliahu Hurvitz 1996-2002 Director View profile
  16. Chaim Hurvitz 1996-2002 Director View profile
  17. Israel Makov 1996-2002 Director View profile
  18. Andrew George Kay 1994-2002 Director View profile
  19. Michael John Harris 1994-1996 Director View profile
  20. Peter Blinman 1994-1996 Director View profile
  21. Timothy James Allington 1996 Director View profile
  22. John Douglas Michelmore 1996 Director View profile
  23. Steven Stocks 1994 Director View profile
  24. Frances Louise Stanton 1994 Director View profile
  25. Grays INN Secretaries Limited 1996-2010 Corporate-secretary View profile

Directors and secretaries as filed at Companies House.

Do you help lead this organisation? Set up its network · How it works

Public contracts won

15 contracts · £15,529,352 total

From Contracts Finder and Find a Tender, the UK Government's public procurement notices, under the Open Government Licence v3.0. Matched to this organisation by company number, charity number or exact name and postcode; every figure links to its source notice.

  • NHS National Generic Pharmaceuticals - Wave 16a Buyer: NHS England £15,529,352 2026-08-27 Source: Find a Tender

    NHS National Framework for Generics Pharmaceuticals Wave 16a Offer reference number: CM/PHG/24/5714 Period of framework agreement: Dates detailed below, with an option or options to extend (at the authority’s discretion) for a period or per…

    Framework
  • Antiviral Generic Medicines Buyer: The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") Value not published Date not published CPV 33600000 Source: Find a Tender

    Supply of Antiviral Generic Medicines to NHS Scotland

    Framework
  • Virus Testing Supplies Buyer: Department of Health and Social Care Value not published Date not published CPV 33140000 Source: Find a Tender

    Provision of virus testing supplies to support the UK COVID-19 Testing Strategy

  • Anti-Infective Drugs 3 Buyer: Velindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on behalf of All Wales Health Boards Value not published Date not published CPV 33600000 Source: Find a Tender

    Generic Anti-Infective Drugs

  • NHS Framework for the Midlands and East, Branded Medicines – Tranche B plus Cytokine Modulators and other Monoclonal Antibodies. Buyer: The NHS Commissioning Board (operating under the name of NHS England) Value not published Date not published CPV 33600000 Source: Find a Tender

    CM/PHR/20/5591/01 - Midlands and East, Branded Medicines – Tranche B. Period of framework: 1 March 2021 to 28 February 2023 with an option to extend (at the Authority’s discretion) for a period or periods up to a total of 24 monthsCM/PHR/20…

    Framework
  • Teriparatide Buyer: The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") Value not published Date not published CPV 33600000 Source: Find a Tender

    Supply of Teriparatide to NHS Scotland.

    Framework
  • Oncology Generics Medicines Buyer: The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority") Value not published Date not published CPV 33600000 Source: Find a Tender

    This Framework Agreement is for the supply of Oncology Generic medicines to NHS Scotland. The Goods have been separated into thirty-nine (39) categories, each of which is identified as a “Lot”. Full details of each Lot is contained in secti…

    Framework
  • NHS National Generic Pharmaceuticals Interim 2 2020 Buyer: The NHS Commissioning Board (operating under the name of NHS England) Value not published Date not published CPV 33690000 Source: Find a Tender

    Hospital only products - All regions:01/02/2021 to 31/01/2022Orals (plus non-parenterals) – Allregions: 01/03/2021 to 28/02/202212 months with an option or options toextend (at the Authority’s discretion) fora period or periods up to a tota…

    Framework
  • NHS Generic Pharmaceuticals - Lenalidomide, Pomalidomide & Thalidomide Buyer: NHS England Value not published Date not published Source: Find a Tender

    NHS National Framework for Lenalidomide, Pomalidomide & Thalidomide. Offer reference number: CM/PHG/24/5716 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) for a …

    Framework
  • NP36126 Antibiotic & Genito Urinary Medicines Buyer: The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) Value not published Date not published CPV 33600000 Source: Find a Tender

    Supply of Antibiotic & Genito Urinary Medicines to NHS Scotland.

    Framework
  • NHS National Branded Interim - 1 June 2026 Buyer: NHS England Value not published Date not published Source: Find a Tender

    Provision of an NHS National Branded Interim - 1 June 2026 01/06/2026 - 30/04/2028 23 Months with an option or options to extend at the discretion of the authority up to a maximum of 25 months

    Framework
  • NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026 Buyer: NHS England Value not published Date not published Source: Find a Tender

    NHS Branded Framework Agreement – Lot 1 - Tranche A for the North of England and Midlands & East. Period of Framework Agreement: 1st September 2026 to 31st August 2028 with an option or option(s) to extend (at the authority’s discretion f…

    Framework
  • NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 Buyer: NHS England Value not published Date not published Source: Find a Tender

    NHS Branded Medicines Tranche B - Lot 1 - London & South of England - CM/PHR/25/5731 Period of Framework Agreement: 1 September 2026 to 31 August 2028 with an option or option(s) to extend (at the Authority’s discretion) for a period or per…

    Framework
  • NHS National Generics Pharmaceuticals - Supply Chain Resilience Buyer: NHS England Value not published Date not published Source: Find a Tender

    NHS National Generics Pharmaceuticals - Supply Chain Resilience Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) for a period or periods up to a total of 48 months…

    Framework
  • Generic, Branded Generic & Proprietary Medicinal Products - Group 18 Buyer: Regional Business Services Organisation, Procurement and Logistics Service Value not published Date not published CPV 33600000 Source: Find a Tender

    Generic, Branded Generic & Proprietary Medicinal Products - Group 18 (6345404)

About

Incorporated
01/07/1935

Ownership

Owned by (2) iOwned byIndividuals and companies registered as having significant control over this company, from the Companies House PSC (persons with significant control) register. People whose ownership could not be confirmed to one individual are not listed as confirmed owners.

Group

  1. Teva UK Limited is controlled by Teva Pharma Holdings Limited
    Evidence
    active 75-100% shares, 75-100% voting, appoints directors · notified 2024-11-05 · source: Companies House PSC register

Ultimately controlled by Teva Pharma Holdings Limited.

12 other companies in this group

Ownership paths are calculated from Companies House persons-with-significant-control filings. Each step shows the filed nature of control and dates; a step marked "ceased" is historical, not current.

Board analysis

Board DNA

How this board is put together, from the Companies House officer record and Charity Commission trustee records - deterministic, no AI.iBoard compositionCounted from the dated Companies House officer record: the current directors only, past directors excluded.

2 directors on the board

8y median 8y
average tenure
9.8y
longest tenure

Directors past 6 years

First-time vs portfolio directors

Portfolio (2)

0
also govern a charity

Left in the last 12 months

Where else this board sits iWhere else this board sitsThe charitable fields these directors govern in elsewhere, by Charity Commission classification. Excludes this company and any charity it is the legal face of.

Manufacturing 14Professional services 8Business services 1Finance 1Retail and trade 1

The sectors these directors govern in elsewhere. This company, and any charity it is the legal face of, are excluded - counting them would just tell you what you are already looking at.

Gaps to watch

  • Several long-serving directors could step down together

Where to look Suggested search: succession planning for long-tenured seats.

Sources

Official record from Companies House. Governance Register calculates the connections.

Record details
Company number
00302461
Status
Active
Type
Private Limited Company
Edition
Register edition compiled 4th October 2026
Labels
Official record from Companies House · Calculated derived by Governance Register.

Contains public sector information licensed under the Open Government Licence v3.0. Report an issue · How we handle data